BLIS Technologies Investor Relations Material

BLIS Technologies Limited is a biotechnology company specializing in the development and production of probiotic products for oral health. The company’s product range includes probiotics aimed at supporting throat health, immune function, and the balance of oral microbiota. Using proprietary bacterial strains, BLIS Technologies develops formulations available in lozenges, powders, and other formats for consumer health. The company’s products are distributed through health stores, pharmacies, and online channels in New Zealand. The company is headquartered in Dunedin, New Zealand, and its shares are listed on the NZX.